← Back to Search

Behavioral Intervention

Resistance Training for Menopause

N/A

Waitlist Available

Research Sponsored by Stanford University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

One year of no periods or categorized as menopause

Female at birth

Must not have

Unable to perform strength training movements

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3 month

Awards & highlights

No Placebo-Only Group

Summary

"This trial aims to test whether a strength training program using resistance bands, and supported by experts, is feasible and acceptable for menopausal women who may face barriers to regular exercise. The goal is to

Who is the study for?

This trial is for women going through menopause who are interested in an at-home strength training program. Participants should be willing to train regularly and have no prior regular strength training routine. Specific eligibility details aren't provided, but typically participants must be healthy enough for physical activity.

What is being tested?

The study is testing a new home-based resistance training program designed specifically for menopausal women. It uses bands and expert guidance to help overcome common barriers like time constraints, safety concerns, and lack of knowledge about exercises.

What are the potential side effects?

Since this intervention involves physical exercise, potential side effects may include muscle soreness, fatigue, or injury if exercises are not performed correctly. Expert support aims to minimize these risks.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have not had a period for one year or am considered menopausal.

Select...

I was assigned female at birth.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:

Select...

I cannot do exercises that require lifting weights.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3 month

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3 month

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3 month for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Liking of the intervention

number of strength exercises the participant logged over the intervention

Secondary study objectives

Change in number of full body weight squats in 60 seconds

Change in total seconds a participant can remain in a wall sit

Number of participants completing post 3 month measure / those randomized and consented

Side effects data

From 2010 Phase 2 trial • 167 Patients • NCT00112151

66%

Other noncardiovascular serious adverse events

13%

Other nonserious adverse events

11%

Persistently elevated PSA

Total serious cardiovascular adverse events

Persistently elevated HCT >= 54%

Elevated AUA

100%

80%

60%

40%

20%

Study treatment Arm

Placebo

Lower-range T

Higher-range T

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

2Treatment groups

Experimental Treatment

Group I: Single Session Resistance Training: Stronger SessionsExperimental Treatment1 Intervention

Home-based strength training exercises would be broken up into 3 weekly sessions throughout the week.

Group II: Shorter Resistance Training: Stronger SnacksExperimental Treatment1 Intervention

Home-based strength training exercises would be broken up into shorter segments throughout the day or week (e.g. a "snack" might be 3 sets of body-weight or band-based squats).

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

Resistance Training

2019

Completed Phase 2

~1230

0 / 3Eligibility criteria met